Fundz

Vita Therapeutics Raises $32 Million In Oversubscribed Series A Financing Led By Cambrian Biopharma To Advance The Development Of Therapies To Treat Muscular Dystrophies

PRIVATEJun 23, 2021

Amount Raised

$32 Million

Round Type

Series A

BaltimoreBiotechnologyHealthcare

Description

Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop cellular therapies that follow an autologous and universal hypoimmunogenic approach, today announced the completion of an oversubscribed $32 million Series A. The financing was led by Cambrian Biopharma with participation from Kiwoom Bio, SCM Life Sciences, and Early Light Ventures.

Quick answer

Vita Therapeutics, Inc. raised $32 Million in a Series A round, dated June 23, 2021. Vita Therapeutics, Inc. is based in Baltimore, Maryland, United States.

How much did Vita Therapeutics, Inc. raise?
Vita Therapeutics, Inc. raised $32 Million in a Series A round on June 23, 2021.
What does Vita Therapeutics, Inc. do?
Vita Therapeutics, a Cambrian Biopharma affiliate, is a cell engineering company harnessing the power of genetics to develop cellular therapies that follow a dual manufacturing strategy, first beginning autologously..
Where is Vita Therapeutics, Inc. based and how big is it?
Vita Therapeutics, Inc. is based in Baltimore, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Vita Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Reimagine Care raised $5.3M on August 6, 2021.
  • PepGen raised $112M on August 6, 2021.
  • Singletto raised $50K on August 6, 2021.
  • CYTRX CORP raised $8.2M on July 29, 2021.
  • Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.
  • Sanara MedTech raised $500K (Seed) on July 27, 2021.

Who to call at Vita Therapeutics, Inc., and when

A new round usually means Vita Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vita Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vita Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vita Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vita Therapeutics, Inc.

Location

1812 ASHLAND AVENUE

Baltimore, Maryland, United States

About

Vita Therapeutics, a Cambrian Biopharma affiliate, is a cell engineering company harnessing the power of genetics to develop cellular therapies that follow a dual manufacturing strategy, first beginning autologously before moving to a universal hypoimmunogenic cell line. Vita was originally founded out of the labs of Dr. Gabsang Lee and Dr. Kathryn Wagner at Johns Hopkins University and the Kennedy Krieger Institute in 2019 by Douglas Falk, M.S. and Peter Andersen, PhD. The company utilizes induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. We are currently working to progress our lead therapeutic, VTA-100, for the treatment of limb-girdle muscular dystrophy (LGMD), into clinical trials. For more information and important updates, please visit www.vitatx.com or follow us on Twitter @Vita_Tx and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vita Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vita Therapeutics, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Vita Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.